Status:
COMPLETED
A Commitment Device for Medication Adherence Among HIV Patients
Lead Sponsor:
National Bureau of Economic Research, Inc.
Collaborating Sponsors:
Emory University
Conditions:
Acquired Immunodeficiency Syndrome
HIV
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We used a randomized trial design combined with a comparison to a non-randomized control group to study patients on appropriate antiretroviral therapy (ART) having virologic failure within a publicly-...
Detailed Description
This study demonstrated the feasibility of using commitment contracts in HIV care. Many previous interventions have produced statistically significant effects on ART adherence that do not persist afte...
Eligibility Criteria
Inclusion
- Attended the Grady Health System Infectious Disease Program (IDP)
- Most recent HIV-1 plasma RNA viral load (pVL) \> 200 copies/mL; this value must have been measured within the prior 18 months and at least 6 months after starting the current ART regimen
- English-speaking
Exclusion
- Using pillboxes
- Were planning to relocate
- Were enrolled in another trial
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01455740
Start Date
October 1 2011
End Date
October 1 2014
Last Update
December 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Ponce Clinic
Atlanta, Georgia, United States, 30308